Trypanosoma cruzi trypomastigotes acquire sialic acid (SA) from host glycoconjugates by means of a plasma membraneassociated trans-sialidase (TS). Here we study the substrate specificity of TS, which differs from all known sialyltransferases in that it does not require cytidine monophosphate (CMD-SA as donor. The T.cruzi TS reversibly transfers SA to saccharides with terminal /3-Gal (but not a-Gal) residues. Donors are saccharides with SA linked to terminal /3-Gal residues by (a2-3), but not (a2-6) bonds. The type of /3-linkage of the terminal Gal residue is of minor importance (/31-4 and 01-6 are slightly better than /Sl-3), whereas chain length and the structure of additional vicinal sugar residues are not relevant. SA on the surface of living trypomastigotes of T. cruzi is transferred back and forth between the parasite surface and acceptor molecules with terminal /3-Gal, either in solution or on the surface of neighbouring mammalian cells. Addition of fucose residue on or close to the terminal galactose impairs TS activity. As a consequence, the enzyme acts poorly on the E-selectin ligand sialyl-Lewis" and its precursor Lewis 1 , and in vitro adhesion of TS-treated neutrophils to L-cells expressing L-selectin is not affected. Modifications in the structure of the (a2-3)-linked iV-acetyl-neuraminic acid (Neu5Ac) (deoxy or methoxv) of the donor molecules do not impair transfer if the changes are at C 9 , whereas changes at C 4 , C 7 and C 8 impair the ability to donate the modified SA. Compounds with modified C 4 and C 8 inhibit TS at relatively high inhibitor/substrate ratios.
Introduction
Trypanosoma cruzi is the flagellated protozoan parasite that causes Chagas' disease, an incurable multisystemic disorder affecting millions of individuals in Latin America (GarciaZapata etai, 1991) . In the mammalian host, the amastigote forms of the parasite multiply in the cytoplasm of cells. After several cycles of replication, the amastigotes transform into flagellated trypomastigotes, which rupture the host cells and enter the circulation. The cycle is sustained when the trypomastigotes invade new cells. The attachment (Schenkman et al., 1991b) and invasion (Schenkman etal., 1992a) of mammalian cells by the trypomastigotes involves a surface membrane sialic acid (SA)-containing, stage-specific epitope (Ssp-3) (Andrews et al., 1987) . The sialylated form of Ssp-3 reacts with a panel of monoclonal antibodies (mAb) (Andrews et al., 1987; Schenkman et al, 1991b Schenkman et al, , 1992a , but removal of SA hinders recognition by the mAbs (Schenkman et al., 1991a) .
Trypanosoma cruzi does not synthesize SA (Schauer et al., 1983) , but acquires it from host glycoconjugates (Previato et al., 1985; Zingales et al., 1987) by means of a membrane trans-sialidase (TS) (Schenkman etal., 1991a; Parodi etai, 1992) . This enzyme differs from all other known sialyl-and glycosyl-transferases in that it does not require a nucleotidesugar as donor. Here we study the substrate specificity of the T.cruzi TS using biochemical and immunological approaches. In addition, we investigate the possibility that the enzyme may influence the migrating patterns of leukocytes by modifying the E-selectin ligands, sialyl-Lewis 1 and sialyl-Lewis a (Tyrrell etal., 1991; Foxall etal., 1992) .
Results

SA acceptors
We initially examined the structural requirements for saccharides and glycolipids to accept SA in the reaction catalysed by TS. We assayed for the ability of these compounds to decrease the amounts of radiolabelled sialyllactose formed in a reaction mixture containing TS, 3'-sialyllactose as a donor of SA and [ l4 C]lactose as the acceptor. As shown in Table IA , transfer of SA to radiolabelled lactose decreases in the presence of disaccharides containing /3-linked, but not a-linked terminal galactopyranosyl residues. Glc, GlcN, GalN, Fuc, GlcNac, GalNac, Man, and disaccharides containing GalNAc, Glc, GlcNAc and Man at the non-reducing end, are inactive. Gal is a poor acceptor (Table IC) , but TS efficiently transfers SA to methyl-/3-Gal, but not to methyl-a-Gal, confirming its specificity towards /3-Iinked galactopyranosyl residues. Nevertheless, oligosaccharides containing non-terminal /3-Gal residues are not good acceptors (see Table IB , 2'-FL and LNFP-I). The reducing end of disaccharides influences the reaction since Gal(i31-4)GlcNAc and GalO31-6)GlcNAc are slightly better acceptors than Gal(/31-3)GlcNAc (Table IA and B) . Chain length does not alter reactivity [compare LNnt with Gal(j3M)GlcNAc, and LNT versus GalO31-3)GlcNAc, in Tables IA and B] . Addition of a fucose residue, however, significantly diminishes the capacity to inhibit formation of [ l4 C]3'-sialyllactose. The effect of the fucose residue decreases as it is positioned further away from the terminal Gal. While reactivity is almost totally blocked if the fucose residue is linked directly to the terminal Gal (see 2'-FL, LNFP-I, Table IB), the presence of branched fucose residues further away (compare LNFP-n and LNFP-V) is less inhibitory. Lewis' 1 (LNFP-III) is a poor acceptor (see Table IB ).
We performed additional experiments using as a donor 4'-methyl-umbelliferyl N-acetyl-neuraminic acid (MU-Neu5Ac). "Glucose (Glc), glucosarrune (GlcN), galactosamine (GalN), fucose (Fuc), A/-acetyl-glucosamine (GlcNAc), A'-aceryl-galactosamine (GalNAc) and mannose (Man) were all tested and found to be negative.
All /3-linked galactosides are sialylated by TS in the presence of MU-Neu5Ac (Figure 1, lanes C, D and E 
TS inhibitors
In Table LID we studied the effect of structural changes in the neuraminic acid residue of GM 3 -gangliosides which, as expected, are good SA donors. Modifications at Cg (deoxy or methoxy) do not alter the ability of the gangliosides to donate SA, whereas changes at C 4 (deoxy or methoxy), C 7 (deoxy) and C 8 (deoxy or epi) are profoundly inhibitory. In addition, Table III shows that some of these compounds are in fact inhibitors of TS activity. GSC-77, GSC-75 and GSC-50 (but not the other gangliosides) partially prevent the transfer of SA from 3'-sialyllactose to [ l4 C]lactose at 1/10 inhibitor/substrate ratios.
The inhibitory activity of the compounds was also shown in vivo. At relatively high concentrations GSC-84, the saccharide portion of GSC-77, partially inhibits sialylation of trypomastigotes grown in bovine serum albumin (BSA) when incubated with 3'-sialyllactose (Table IV) . GSC-84 was used instead of GSC-77 because the ceramide portion of GSC-77 caused aggregation of the trypomastigotes (data not shown). Nevertheless, complete inhibition of TS was not achieved with any of the gangliosides, thus rendering them of little use for biological experiments. Table HI also shows that 2,3-dehydro-2-deoxy-Neu5Ac, a potent inhibitor of bacterial and viral sialidases (Meindl et al., 1974) , has little or no effect on TS activity.
Ssp-3 is a donor of SA
Previous studies demonstrated that the Ssp-3 epitope of trypomastigotes (Andrews et al., 1987) is assembled through the TS-catalysed transfer of (a2-3)-linked SA from host macromolecules to parasite surface molecules (Schenkman et al., 1991a) . To determine whether this reaction is reversible, and whether Ssp-3 can in turn donate SA to other cells, we mixed parasites grown in Dulbecco's modified Eagle's medium (DMEM)-BSA with parasites grown in DMEM-fetal bovine serum (FBS) and incubated the mixture for 60 min at 37°C. The mixture was then subjected to FACS analysis using mAb 3C9 as a revealing reagent. The reactivity of this mAb with Ssp-3 is dependent on the presence of SA in the epitope. As shown in Figure 2 , parasites grown in DMEM-BSA (therefore in the absence of SA donors) (A) are less intensely stained (mean fluorescence = 242) than those grown in medium containing FBS (B) (mean fluorescence = 1371). After they are incubated together, the parasites have intermediate staining intensity (C) (mean fluorescence = 1090).
That Ssp-3 can act as a donor of SA was further demonstrated by incubating parasites grown in DMEM-FBS in medium containing 1 mM of various oligosaccharides. The Ssp-3 epitope is lost if the medium contains saccharides with terminal /3-Gal residues, such as lactose and /3-methyl-Gal, but not if it contains saccharides with a-terminal Gal residues, such as melibiose or a-methyl-Gal (see Table V) .
Lack of TS effect on E-selectin ligand
Sialic acid plays an important role in the selectin-mediated cell adhesion (Tyrrell et al., 1991; Foxall et al., 1992) . Additional experiments were performed to examine the effect of TS on the interaction between selectins and their ligands, sialyl-Lewis a and sialyl-Lewis*. Neutrophils were treated with TS in the presence of lactose (as a SA acceptor), or with Vibrio cholerae sialidase (as a positive control). The neutrophils were then assayed for their ability to attach to L-cells transfected with E-selectin. Treatment with sialidase, but not with TS, abrogated the binding (Figure 3) .
In order to document the activity of TS on SA-containing molecules from the neutrophil plasma membrane, we performed a series of control experiments. Neutrophils were preincubated with phosphate-buffered saline (PBS), with sialidase, or with TS in the presence of lactose. The cells were washed and reincubated with TS in the presence of [D-glucose-l- 14 C]-lactose. Negative controls consisted of cells incubated with the labelled acceptor, but in the absence of TS. As shown in Table  VI , labelled sialyllactose is formed in the incubation mixtures containing neutrophils which had been pre-treated with PBS, 
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Terminal sacchandes Concentration 10 0«M)' 100 1000 10 000 but not with sialidase, or with TS in the presence of lactose. We conclude that TS removes (a2-3)-linked SA from the plasma membrane of the neutrophils. However, the E-selectin ligands, sialyl-Lewis x and sialyl-Lewis", that contain branched fucose, are less (or not) affected.
Discussion
Glycosyl transfer reactions are common in nature, the most common type being the transfer of a glycosyl unit from a sugar 544 nucleotide to an acceptor. Transglycosylation in the absence of nucleotide-sugars is unusuaJ because this process is thermodynamically unfavourable (Cote and Tao, 1990) . Nevertheless, many enzymes that primarily catalyse the hydrolysis of oligosaccharides can perform transglycosylation reactions, albeit much less efficiently. The hydrolysis of the glycosidic bond by these enzymes is simply a special case of transglycosylation, in which the acceptor is water. This is also the case for the T.cruzi TS, whose sialidase activity (Pereira, 1983) was detected prior to its trans-sialidase activity (Schenkman et al., Table II 1991a). However, the T.cruzi enzyme is exceptional in that it is more efficient in transferring than in hydrolysing SA (Parodi etal, 1992; Schenkman et al, 1992b) . Also, in contrast with the glycosyltransferases, it does not use CMP-SA (which contains /3-linked SA) as a donor of SA (Corfield and Schauer, 1982) .
In this paper, we characterize the substrate specificity of the T.cruzi TS using biochemical and immunological approaches. We show that saccharides with terminal /S-Gal (but not a-Gal) are acceptors, and saccharides with terminal Neu5Ac (a2-3)-linked to /3-Gal [but not (a2-6)-linked], are donors of SA (Tables I and II) . The presence of a residue in /3-linkage to Gal is necessary for catalysis; Gal is not an acceptor, although in aqueous solutions Gal occurs mostly as a /3-anomer (El Khadem, 1988) . On the other hand, a single linked carbon atom (methyl-/3-Gal) is sufficient to obtain reactivity (Table I) . TS also transfers SA from MU-Neu5Ac, but methyl-umbelliferone is not an acceptor (Schenkman etal., 1992b) . A possible interpretation of these findings is that during catalysis a sialylated enzyme intermediate is formed and the desialylated product of the reaction is released from the pocket. The enzyme-bound SA is then transferred to any available £-Galcontaining structure, provided it can be accommodated in the enzyme pocket. Although chain length and the structure of additional vicinal sugar residues seem irrelevant, addition of a fucosyl side chain to the terminal |3-Gal inhibits transfer, most likely because it prevents entrance of the saccharide in the active site of TS (Tables I and II) , as in the case of mammalian sialyl-transferases (Paulson etal., 1978) . Fluorescence Intensity Fig. 2 . The acquisition of SA by trypomastigotes is reversible. Parasites were washed in DMEM-BSA and divided into two aliquots. One was incubated with the mAb 3C9 against the Ssp-3 epitope. Parasites were then stained with goat anti-mouse IgG-FITC and analysed by FACS. Three different samples of trypomastigotes were analysed, originating from cultures in DMEM-BSA (A), cultures in DMEM-FBS (B), or a mixture of equal numbers of (A) and (B) which was pre-incubated at 37°C for 60 min prior to staining (C). Unshaded curves represent the background obtained by staining with the secondary antibody only; shaded curves represent the 3C9-stained samples. Table V . Ssp-3 is a donor of sialic acid. Trypomastigotes were grown in medium containing BSA or FCS as described. Parasites were then incubated with different saccharides (1 mM) for 1 h at 37°C, stained with the 3C9 antibody and analysed by FACS As shown in Table HI , the compounds with modified C 4 and C 8 (deoxy) in the (a2-3)-linked Neu5Ac are inhibitors of TS, suggesting that these are sites for SA recognition/catalysis. This is in contrast with the saccharides bearing (a2-6)-or (a2-9)-linked SA, which are neither donors nor inhibitors and probably do not enter the enzyme pocket.
Every donor molecule tested (with the exception of MUNeu5 Ac, see above) can become an acceptor after release of SA (Tables I and II) . This is also valid for Ssp-3, the sialylated stage-specific epitope of T.cruzi (Andrews etai, 1987) . Studies performed with live trypomastigotes show that SA can be transferred back and forth between the parasite surface and acceptor molecules (Figure 2 , Tables V and VI). It is conceivable that this continuous transfer of SA might in fact be part of the molecular events occurring during parasite attachment to and invasion of host cells (Schenkman et al., 1991b) .
On the basis of the initial studies on the substrate specificity of TS, it was suggested (Kahn et al., 1991; Schenkman et al., 1991a) that TS might remove the SA from the selectin ligands [sialyl-Lewis x and sialyl-Lewis" (Tyrrell et al., 1991; Foxall et al., 1992) ]. If this were true, the TS shed from the parasite surface (Frevert etai, 1992b; Schenkman etai, 1992) , and found in the circulation during the acute stages of the infection (de Titto and Araujo, 1988; Affranchino etai, 1989) , might disrupt specific interactions between leukocytes, platelets and the vascular endothelium. However, the data in Table n, showing that fucosylated saccharides are not very good substrates for the TS, render this unlikely. The biochemical data were substantiated by direct experiments showing that in vitro adhesion of TS-treated neutrophils to L-cells expressing L-selectin was not significantly affected (Figure 3) .
TS is a homopolymer with subunits of 160 000-200 000 M r , with the amino-terminal half of the polypeptide chain containing the catalytic site (Parodi etai, 1992; Uemura etai, 1992) . This region of the molecule contains consensus sequences (S-X-D-X-G-X-T-W) which are homologous to the ASP boxes in the viral and bacterial sialidases (Roggentin etai, 1989; Russo etai, 1990; Kahn etai., 1991; Pollevick et al, 1991; Uemura et al, 1992) . In spite of these similarities, TS has properties distinct from the other sialidases. TS is most active at neutral pH, whereas most sialidases are more active at acidic pH. Competitive inhibitors of sialidases, such as 2,3-dehydro-3-deoxy-Neu5Ac, do not inhibit TS (Table HI) . In fact, ASP boxes are found in proteins that do not have sialidase activity, but are involved in binding to saccharides (Takle and Cross, 1991) . Similarly, ASP boxes are found in trypomastigote surface molecules lacking sialidase activity (Takle and Cross, 1991; Uemura etai., 1992) . Perhaps ASP boxes function in the recognition of saccharides, rather than in catalysis, and may be required to attach T.cruzi trypomastigotes to cells or to the extracellular matrix. The recent cloning of several members of the TS family of genes, some of which lack TS activity (Uemura et al, 1992) , should facilitate the identification of domains of the polypeptide chain involved in the recognition of donors and acceptors of SA, as well as in catalysis.
Materials and methods
Parasites
Trypanosoma cruzi trypomastigotes, Y strain (Silva and Nussenzweig, 1953) , were obtained from infected LLC-MK 2 cells (ATCC-CCL-7, Rockville, MD), grown in low-glucose DMEM with penicillin and streptomycin (Gibco, Grand Island, NY), containing 10% FBS. Subconfluent cultures of LLC-MKj cells, kept at 37°C in 5% CO 2 , were infected with 5 x 10 6 trypomastigotes/ 75 cm 2 flask. The parasites remaining extracellular after 24 h were removed and the cultures maintained in 10% FBS-DMEM. In some experiments, the FBS-containing medium was removed during the third day following infection, the monolayers washed twice with PBS, and culture continued in DMEM containing 0.2% BSA (ultrapure, Boehringer Mannheim, Indianapolis, IN) and 20 mM Hepes (pH 7.4) (0.2% BSA-DMEM). There was no difference in the numbers or morphology of parasites obtained from cultures in 0.2% BSA-DMEM (BSA-trypomastigotes) or in FBS-DMEM (FBS-trypomastigotes). On day 5 after infection, the culture supematants containing trypomastigotes, intermediate forms and amastigotes were centrifuged at 2000 g for 5 min and incubated at 37°C. The motile trypomastigotes were collected from the supernatant after 2 h.
Enzyme purification TS activity was purified as described previously (Schenkman et al., 1992b) , with slight modifications. Pooled supematants from cultures of BSA-trypomastigotes were passed through a 0.22 /tm Millipore filter and then concentrated -20 times by filtration through Amicon membranes with a 300 000 mol. wt T.cruzf trans-sialidase substrate specificity cutoff (XM300, Amicon Co, Lexington, MA). The supernatants were adjusted to 0.5 M NaCI, I mM CaCl 2 , 1 raM MgCl 2 , 1 mM MnCl 2 , and incubated with Concanavalin A-Sepharose (Pharmacia LKB Biotechnology, Uppsala, Sweden) equilibrated with 0.1% NP-40, 0.5 M NaCI, 50 mM Tris-HCl (pH 7.4). The Sepharose beads were washed with 25 ml of the equilibration buffer and the enzyme eluted by overnight incubation of the beads with 0.5 M a-methyl-o-mannoside in the same buffer. The eluate was then dialysed against PBS.
Alternatively, the material concentrated by passage through Amicon membranes was incubated with mAb 39 (Schenkman etal., 1991b) immobilized on a trcsyl-activated agarose column (Schlekher & Schuell, Keene, NH), prepared according to the manufacturer's instructions. The column was washed with 0.15 M NaCI, 50 mM Tris-HCl (pH 7.4), 0.05* NP^O, and the enzyme eluted with 3.5 M MgClj, 20 mM sodium phosphate (pH 6.0). The eluate was immediately filtered through a G-25 column equilibrated with 20 mM Tris-HCl (pH 8.0).
Enzyme activity measurements
TS activity was assayed using two different procedures, (i) By incubating purified enzyme in 20 mM Hepes buffer (Sigma H-3375) (pH 7.2) in the presence of 3'-sialyllactose and [r>-glucose-ll4 C]lactose (60 mCi/mmol) (Amersham, Arlington Heights, IL) as described previously (Passanhi and Hart, 1988) . A standard assay contained 1 mM 3'-sialyllactose and 25 000-^tO 000 c.p.m lactose in a final volume of 50 /d. This mixture was incubated for 30 min at 37°C and the reaction terminated by the addition of 1 ml of water, followed by passage through a 1 ml QAE-Sephadex A50 column equilibrated in water (Pharmacia LKB). The radioactive ohgosaccharides were eluted with 0.5 ml of 1 M ammonium formate. The effectiveness of enzyme acceptors or inhibitors was assayed by adding them at various concentrations to a standard reaction mixture. The ability of different sialylated molecules to donate their SA was evaluated by substituting them in the reaction mixture for 3'-sialyl lactose at various concentrations. Activity was expressed as percent reduction of control counts for the acceptor/inhibitor studies, or as percent of control counts for the donor as compared to a standard reaction run in parallel, (ii) Transfer activity was also measured by incubating affinity purified TS with 50 nmol of MUNeu5Ac and 40 nmol of the indicated oligosaccharide, in 20 /J 5 mM Hepes (pH 7) for 3 h at room temperature. In the control reactions, TS or heatinactivated TS were incubated with MXJ-Neu5Ac alone. The reactions were stopped by adding 20 /il ethanol and the products analysed by TLC on silica gel 60 plates (EM Science, HPTLC Fertigplatten Kieselgel 60F254, 10 x 10 cm) and chromatographed in ethanol-n-butanol-pyridine-water-acetic acid [100:10:10:30:3 (v/v)]. SA-containing molecules were visualized by resorcinol staining. Neu5Ac, MU-Neu5Ac, 3'-sialyllactose and 6'-sialyllactose were used as standards.
Saccharides, ceramides and gtycoproteins
Ail products were from Sigma, except those marked OG which were purchased from Oxford Glycosystem; or those marked BM, which were purchased from Boehringer Mannheim; or those synthesized at Gifu University, indicated by a reference. 0.2 U/ml sialidase (V.cholerae, protease-free, azide removed by dialysis, Boehringer Mannheim), purified TS with lactose (1 mM) or an equal volume of PBS. Neutrophils were incubated at 37°C for 90 min, spun down and washed twice with DMEM.
Sialic acid acceptors, ft) Monosaccharides
L-Cell cultures were washed once with DMEM without FBS and co-incubated with 2 ml of a suspension of neutrophils at 2 x lOVml. L-Cells and neutrophils were incubated for 60 min at 37°C on a rotary shaker, after which the medium was removed and the wells washed six times with DMEM without FBS. Rosetting of neutrophils around the adherent L-cells was evaluated microscopically and expressed as percent of L-cells with more than one neutrophil attached.
